Search results for "Central sleep apnea"

showing 7 items of 7 documents

Infantile Central Sleep Apnea - Improvement With Acetazolamide

1999

Central sleep apneabusiness.industryAnesthesiaPediatrics Perinatology and Child HealthMedicinebusinessmedicine.diseaseAcetazolamidemedicine.drugPediatric Research
researchProduct

Sleep disordered breathing in medically stable patients with myasthenia gravis

2007

We investigate sleep and breathing in clinically stable myasthenia gravis (MG) patients and ask weather sleep disordered breathing (SDB) is causally linked with MG. Nineteen MG patients with a mean disease duration of 9.7 years underwent sleep studies in two consecutive nights. The primary outcome measure was the respiratory disturbance index (RDI) in terms of snoring and apneas/hypopneas. Further outcome measurements were total sleep time, sleep stage distribution and the number of arousals. A clinically relevant SDB in terms of obstructive sleep apnea (OSA) (defined as RDI > 10/h) was found in four patients. There were only a few central apneas (central apnea index: 0.19 +/- 0.4/h). We di…

Central sleep apneabusiness.industryCentral apneaSleep apneamedicine.diseaseSleep in non-human animalsMyasthenia gravisnervous system diseasesrespiratory tract diseasesObstructive sleep apneaNeurologySleep and breathingAnesthesiaRespiratory disturbance indexMedicineNeurology (clinical)businessEuropean Journal of Neurology
researchProduct

Acetazolamide treatment for infantile central sleep apnea.

2001

Central sleep apnea is a common respiratory pattern in healthy neonates. Nevertheless, frequent central sleep apnea associated with drops in oxygen saturation may contribute to infantile morbidity. Recently, low-dose acetazolamide was shown to reduce symptomatic central sleep apnea in adults. We treated 12 infants, median conceptional age 42 weeks (range, 40-44 weeks), with central sleep apnea. In all cases, the central apnea index was >40/h total sleeping time (apnea ≥ 3 sec). The cumulative duration of drops in oxygen saturation below 90% was more than 3 min/h total sleeping time. All individuals received acetazolamide 7 mg/kg/day (orally, divided in three doses) for 11 weeks. Polysomn…

MaleCentral sleep apneaPolysomnographyPolysomnography030226 pharmacology & pharmacyDrug Administration ScheduleHypoxemia03 medical and health sciences0302 clinical medicineSleep Apnea SyndromesmedicineHumansOximetryRespiratory systemCarbonic Anhydrase InhibitorsOxygen saturation (medicine)medicine.diagnostic_testbusiness.industry05 social sciencesInfant Newborn050301 educationSleep apneaApneamedicine.diseaseAcetazolamideAnesthesiaPediatrics Perinatology and Child HealthFemaleNeurology (clinical)medicine.symptombusinessAcetazolamide0503 educationmedicine.drugJournal of child neurology
researchProduct

New modes in non-invasive ventilation

2016

IF 2.536; International audience; Non-invasive ventilation is useful to treat some forms of respiratory failure. Hence, the number of patients receiving this treatment is steadily increasing. Considerable conceptual and technical progress has been made in recent years by manufacturers concerning this technique. This includes new features committed to improve its effectiveness as well as patient-ventilator interactions. The goal of this review is to deal with latest advances in ventilatory modes and features available for non-invasive ventilation. We present a comprehensive analysis of new modes of ventilator assistance committed to treat respiratory failure (hybrid modes) and central and co…

Pulmonary and Respiratory MedicineComplex sleep apneamedicine.medical_specialtyCentral sleep apneaAdaptive servo ventilation[ SDV.MHEP.PED ] Life Sciences [q-bio]/Human health and pathology/PediatricsCheyne-stokes respirationReview030204 cardiovascular system & hematologyPositive airway pressureRespiratory failure[SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tractAssured pressure support03 medical and health sciences0302 clinical medicinemedicineNeurally adjusted ventilatory assistVentilatory modesHumansIntensive care medicineObstructive pulmonary-diseaseComplex sleep-apnea[SDV.MHEP.PED]Life Sciences [q-bio]/Human health and pathology/PediatricsNoninvasive Ventilationbusiness.industryDiaphragm electrical-activityNon invasive ventilationmedicine.diseaseNeuro adjusted ventilatory assistClinical PracticeRandomized controlled-trialAdaptative servo ventilationChronic heart-failure030228 respiratory systemRespiratory failurePediatrics Perinatology and Child HealthBreathingCentral sleep apneabusinessRespiratory InsufficiencyImproves cardiac-function[ SDV.MHEP.PSR ] Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract
researchProduct

Sleep Apnea: New Insights

2004

Sleep apnea is the most common disorder of breathing during sleep. It is defined as repeated episodes of obstructive apnea and hypopnea during sleep, together with daytime sleepiness or altered cardiopulmonary function [1]. There are three syndromes of upper airway closure during sleep: obstructive sleep apnea (OSA), obstructive sleep hypopnea, and upper airway resistance. These three syndromes share two features: excessive daytime sleepiness and arousal associated with increased ventilatory effort in response to upper airway closure. The specific sites of narrowing or closure and upper airway dysfunction are influenced by the underlying neuromuscular tone, upper airway muscle synchrony, an…

medicine.medical_specialtyCentral sleep apneabusiness.industrymedicine.medical_treatmentSleep apneaExcessive daytime sleepinessmedicine.diseaseSleep in non-human animalsrespiratory tract diseasesObstructive sleep apneaAirway resistanceInternal medicinemedicineCardiologyContinuous positive airway pressuremedicine.symptombusinessHypopnea
researchProduct

Focus on functional delayed central sleep apnea following cervical laminectomy. An example of respiratory dysfunction in restorative neurosurgical pr…

2017

In sleep-related breathing disorders, sleep apnea is a clinical symptom that can be categorized as obstructive sleep apnea (OSA) or mixed apnea by analysis using poly-somnography. The occurrence of delayed central sleep apnea (CSA) is an extremely rare complication of cervical laminectomy for spondylotic myelopathy. So far only three studies concerning such an event have been reported in the literature. Naim-ur-Rahman, in 1994, reported a case of postoperative CSA following C3-C6 laminectomy, and Visocchi and colleagues, in 2014, in two studies, stressed the lack of association with any other neurological sign of spinal cord damage. No definitive mechanism has been recognized so far for del…

medicine.medical_specialtyCentral sleep apneamedicine.medical_treatmentPolysomnographyAudiology03 medical and health sciencesPostoperative Complications0302 clinical medicineCervical laminectomymedicineParalysisHumansPhrenic nerveCentral sleep apnea; Cervical laminectomy; Obstructive sleep apnea; Surgery; Neurology (clinical)medicine.diagnostic_testSettore MED/27 - Neurochirurgiabusiness.industryLaminectomyLaminectomySleep apneaApneamedicine.diseaseSleep Apnea CentralObstructive sleep apneaObstructive sleep apneaAnesthesiaCervical Vertebrae030211 gastroenterology & hepatologySurgerySpondylosisCentral sleep apneaNeurology (clinical)medicine.symptombusinessSpinal Cord Compression030217 neurology & neurosurgery
researchProduct

Sleep-disordered breathing in the elderly

2009

Purpose: The prevalence of sleep-disordered breathing (SDB) increases with aging. SDB is a risk of hypertension, and both might lead to cognitive decline. However, the role of SDB and hypertension on the pathogenesis of age-related cognitive decline remains unclear. We examined the effects of these two diseases on cognitive function in elderly adults.

obstructive sleep apnea central sleep apnea chronic heart failure chronic obstructive pulmonary diseaseSettore MED/10 - Malattie Dell'Apparato Respiratorio
researchProduct